I will say that while I'm not a research scientist by trade right now, I've get a pretty solid background to understand a lot more than an average investor. As you are leading me to water, I'm sure you've already got an idea of my main interest here. Am I truly interested in this company, for many reasons, yes, I am deeply interested. Xechem International, with the many divisions, products and ideas was on track to be a global pharmaceutical giant and I truly believe that it can still be, but not with what's happening now. That's why I'm questioning closing the lab. I understand it was a cost saving measure, but they could have cut that space by 1/3 or 1/2, saved space and kept working on the long term projects suce as the nutraceuticals, the work on the Malaria and diabetes drugs and the list could go on. If you've read the annual reports (which I have for the last few years), you see the vision. Yes, the short term goal is to get the SCD product in the hands of as many people as possible, not only for revenue, but because Xechem has a product that can help a tremendous number of people from suffering, but when you look at the list of other diseases, ailments, etc., that was planned to be "attacked" you can see where things were going. Compassion while earning isn't a bad combination.
Market Data 
Markets 
